Search by Drug Name or NDC

NDC 00009-5093-01 Ellence 2 mg/mL Details

Ellence 2 mg/mL

Ellence is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pharmacia & Upjohn Company LLC. The primary component is EPIRUBICIN HYDROCHLORIDE.

MedlinePlus Drug Summary

Epirubicin is used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. Epirubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.

Related Packages: 00009-5093-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Epirubicin

Product Information

NDC	00009-5093
Product ID	0009-5093_27ab0561-e4f8-4db3-b1c5-dc22ccfdc5c6
Associated GPIs	21200042102045
GCN Sequence Number	061494
GCN Sequence Number Description	epirubicin HCl VIAL 200MG/0.1L INTRAVEN
HIC3	V1D
HIC3 Description	ANTIBIOTIC ANTINEOPLASTICS
GCN	97282
HICL Sequence Number	006578
HICL Sequence Number Description	EPIRUBICIN HCL
Brand/Generic	Brand
Proprietary Name	Ellence
Proprietary Name Suffix	n/a
Non-Proprietary Name	epirubicin hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	2
Active Ingredient Units	mg/mL
Substance Name	EPIRUBICIN HYDROCHLORIDE
Labeler Name	Pharmacia & Upjohn Company LLC
Pharmaceutical Class	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA050778
Listing Certified Through	2024-12-31

Package

NDC 00009-5093-01 (00009509301)

Pricing Information	N/A
NDC Package Code	0009-5093-01
Billing NDC	00009509301
Package	1 VIAL, SINGLE-DOSE in 1 CARTON (0009-5093-01) / 100 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date	1999-09-15
NDC Exclude Flag	N